Sodium Chloride Symporter Inhibitors: Clinical Trials

10 trials of Sodium Chloride Symporter Inhibitors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 unknown, 1 withdrawn. 5 Phase 4, 1 Early Phase 1, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 45Completed 3, Unknown 1, Withdrawn 1
Early Phase 11Completed 1
Not applicable1Completed 1
Phase 31Completed 1

Follow Sodium Chloride Symporter Inhibitors: new trials by email Literature Review of Sodium Chloride Symporter Inhibitors trials Research Report on Sodium Chloride Symporter Inhibitors

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Diuretic Strategies in Hospitalized Heart Failure
Loop Diuretics vs. loop + thiazide diuretics - Heart Failure
Phase 4WithdrawnStanford University2023-07-012023-04-12
Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD
Spironolactone, Chlortalidone - Renal Insufficiency, Chronic, Cardio-Renal Syndrome
Phase 4UnknownUniversity Hospital Birmingham1542014-06-012018-01-19
ACE Inhibitors Combined With Exercise for Seniors - Pilot Study
Exercise, ACE inhibitor + exercise, Thiazide diuretic + exercise - Hypertension, Aging
CompletedUniversity of Florida1042014-01-012017-07-05
Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study
Herbs, Antihypertensive drugs - Primary Hypertension, Hypertension, Resistant to Conventional Therapy
Early Phase 1CompletedChina Academy of Chinese Medical Sciences1922013-08-012016-09-07
Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension
Lisinopril, Amlodipine, Hydrochlorothiazide - Essential Hypertension
Not applicableCompletedThe University of Texas Health Science Center, Houston422013-06-012018-11-15
Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives
all approved antihypertensive drugs; all approved statins - Stroke, Transient Ischemic Attack
Phase 4CompletedIstituto Auxologico Italiano2002013-04-012024-02-20
Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension
GROUP A: Valsartan plus Chlorthalidone, GROUP B: Valsartan, GROUP C: Chlorthalidone - Hypertension
Phase 3CompletedFarma de Colombia SA1242013-04-012016-01-26
Diuretics In the Management of Essential Hypertension (DIME) Study
Thiazide diuretics, No diuretics - Hypertension
Phase 4CompletedKyoto University11302004-04-012024-06-14
Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients
Angiotensin receptor blockers, β-blockers, thiazide diuretics - Cardiovascular Disease
Phase 4CompletedSeiji Umemoto, M.D., Ph.D.35012003-05-012012-02-22
Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events
Anti-hypertensive drug treatment - Systemic Arterial Hypertension, Hypertension Resistant to Conventional Therapy
CompletedUniversidade Gama Filho922001-06-012013-04-22

Conditions studied

Hypertension (6)  ·  Essential Hypertension (4)  ·  Heart Failure (2)  ·  Hypertension Resistant to Conventional Therapy (2)  ·  Myocardial Infarction (2)  ·  Stroke (2)  ·  Cardio-Renal Syndrome (1)  ·  Cardiovascular Diseases (1)  ·  Dementia (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Ischemic Attack, Transient (1)  ·  Motor Activity (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

China Academy of Chinese Medical Sciences (1)  ·  Farma de Colombia SA (1)  ·  Istituto Auxologico Italiano (1)  ·  Kyoto University (1)  ·  Seiji Umemoto, M.D., Ph.D. (1)  ·  Stanford University (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  Universidade Gama Filho (1)  ·  University Hospital Birmingham (1)  ·  University of Florida (1)

Countries

United States (3)  ·  Japan (2)  ·  Brazil (1)  ·  China (1)  ·  Colombia (1)  ·  Ecuador (1)  ·  Russia (1)  ·  United Kingdom (1)

Top investigators

Alberto Zanchetti (1)  ·  Gemma Slinn (1)  ·  Ivan Cordovil, MD (1)  ·  Joyce P Samuel, MD, MS (1)  ·  Juan D Romero, MD (1)  ·  Lisheng Liu, MD (1)  ·  Paulo R Benchimol-Barbosa, MD, DSc (1)  ·  Priscilla Campos (1)  ·  Shinichiro Ueda, MB, ChB, PhD (1)  ·  Takao Saruta, MD, PhD (1)  ·  Tara Chang, MD, MS (1)  ·  Thomas Buford, Ph.D. (1)  ·  Toshio Ogihara, MD, PhD (1)

Results publications

PMID 11904577, PMID 21610513, PMID 22278623, PMID 23985703, PMID 24979303, PMID 25031188, PMID 26490089, PMID 30202211, PMID 30842257, PMID 31995012, PMID 32905623, PMID 36398903

NIH funding

5KL2TR000370 (1)